http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#head http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#assertion http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#provenance http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#publicationInfo http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#assertion http://bio2rdf.org/drugbank:DB00515 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00515_DB01097 http://bio2rdf.org/drugbank:DB01097 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00515_DB01097 http://bio2rdf.org/drugbank_resource:DB00515_DB01097 http://purl.org/dc/terms/identifier drugbank_resource:DB00515_DB01097 http://bio2rdf.org/drugbank_resource:DB00515_DB01097 http://purl.org/dc/terms/title DDI between Cisplatin and Leflunomide - Immunosuppressants such as cisplatin may enhance the adverse/toxic effect of leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased. Consider eliminating the use of a leflunomide loading dose in patients who are receiving other immunosuppressants in order to reduce the risk for serious adverse events such as hematologic toxicity. Also, patients receiving both leflunomide and another immunosuppressive medication should be monitored for bone marrow suppression at least monthly throughout the duration of concurrent therapy. http://bio2rdf.org/drugbank_resource:DB00515_DB01097 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00515_DB01097 http://www.w3.org/2000/01/rdf-schema#label DDI between Cisplatin and Leflunomide - Immunosuppressants such as cisplatin may enhance the adverse/toxic effect of leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased. Consider eliminating the use of a leflunomide loading dose in patients who are receiving other immunosuppressants in order to reduce the risk for serious adverse events such as hematologic toxicity. Also, patients receiving both leflunomide and another immunosuppressive medication should be monitored for bone marrow suppression at least monthly throughout the duration of concurrent therapy. [drugbank_resource:DB00515_DB01097] http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#provenance http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#publicationInfo http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#signature.MCwCFHTKQ224g92b http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#signature.MCwCFHTKQ224g92b http://purl.org/nanopub/x/hasSignature MCwCFHTKQ224g92bJhPrlboR9TtyHB77AhQ3+bCt0Rdxmob1IwTHkReMQMhhLg== http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#signature.MCwCFHTKQ224g92b http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE http://purl.org/dc/terms/created 2018-03-30T11:13:12.584+02:00 http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE#signature.MCwCFHTKQ224g92b http://bio2rdf.org/drugbank_resource:DB00515_DB01097_nanopub.RAl3Q0B8YHx2OvIZvhBmshw8hiBcCrWQMW5ajEq9sbXDE http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234